InsidersTradesSigma
Follow the Egetis Therapeutics AB (publ) share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Egetis Therapeutics AB (publ) has published 28 insider filings. Market capitalisation: €3.7bn. The latest transaction was reported on 3 September 2026 (Purchase). Among the most active insiders: Christian Sonesson. The full history is accessible without an account.
28
Insider Decl.
n/a
Thresholds
€52,213
19 ops.
Buy Volume
€842,189
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Egetis Therapeutics AB (publ) Buy (bullish), based on 3 analysts. Average price target: SEK 15.33.
34Σ signal
Fundamental score
Ranked 27,596 of 29,063 companies
15.9
score / 100
Value18
Quality14
FCF yld-7.2%
Earn yld-9.2%
EV/EBITDA·
ROE-97%
Gross mgn20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations28 total
1,099 shares0AktieISIN SE0003815604FI:csv-24e02d5ee31cbbc703d2
1,099 shares0AktieISIN SE0003815604FI:csv-87582a6f9181baf68618
594 shares@ SEK 7.7719AktieISIN SE0003815604FI:csv-7bfe64144f561ff8f691
1,099 shares0AktieISIN SE0003815604FI:csv-49cfae9c437db1777dba
2,198 shares0AktieISIN SE0003815604FI:csv-52c25c2a4067c0f7ea17
158,928 shares@ SEK 6.500.036% mcap48.3% of flowAktieISIN SE0003815604FI:csv-2095cc230f6097f680ca
264,880 shares0AktieISIN SE0003815604FI:csv-175d73b1ea8853239cdb
37,202 shares0AktieISIN SE0003815604FI:csv-e9e8616ad9038e8953be
158,928 shares@ SEK 6.500.033% mcap93.6% of flowAktieISIN SE0017770027FI:csv-f87ec71e64a442ce7e24
264,880 shares0AktieISIN SE0003815604FI:csv-1ef0079ec6f2384808c5
286,071 shares@ SEK 6.500.059% mcap100.0% of flowAktieISIN SE0003815604FI:csv-080acb505ed56ada1bf4
529,761 shares0AktieISIN SE0003815604FI:csv-841ca189a7c635e1917d
529,761 shares0AktieISIN SE0003815604FI:A003Y632-1
264,880 shares0AktieISIN SE0003815604FI:A003Y653-1
264,880 shares@ SEK 6.500.054% mcap94.6% of flowAktieISIN SE0003815604FI:csv-4f6c60d76c6f9c961f8e
264,880 shares0AktieISIN SE0003815604FI:csv-5062421e5700a2577d48
264,880 shares0AktieISIN SE0003815604FI:A003Y615-1
119,529 shares@ SEK 6.500.024% mcap46.5% of flowAktieISIN SE0003815604FI:csv-6bcea8f583b1cb375000
265,620 shares0AktieISIN SE0003815604FI:csv-c81607ca7a4dc540e585
153,631 shares@ SEK 6.500.031% mcap44.8% of flowAktieISIN SE0003815604FI:csv-fd45067293b119868f0a
264,880 shares0AktieISIN SE0003815604FI:csv-20298035c5d4dc97dbf5
153,631 shares@ SEK 6.500.031% mcap81.3% of flowAktieISIN SE0003815604FI:A003Y582-1
119,529 shares@ €0.59480.024% mcap86.9% of flowAktieISIN SE0003815604FI:A003Y593-1
60,000 shares@ €0.35090.0073% mcap18.7% of flowAktieISIN SE0003815604FI:A003U276-2
25,000 shares@ €0.43030.0037% mcap13.1% of flowAktieISIN SE0003815604FI:A003U284-1
25 of 28 declarations
Acerca de Egetis Therapeutics AB (publ)
Egetis Therapeutics AB (publ) es una empresa biofarmacéutica sueca centrada en el desarrollo de tratamientos para enfermedades raras. Cotiza en la Bolsa de Estocolmo (XSTO).
